Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (11): 703-704.
DOI: 10.19803/j.1672-8629.2019.11.15
YUWEN Lixia, KONG Yingli, YUAN Yaohui, WANG Lihua*
Received:2019-11-27
Revised:2019-11-27
Online:2019-11-20
Published:2019-11-27
CLC Number:
YUWEN Lixia, KONG Yingli, YUAN Yaohui, WANG Lihua. One Case of Severe Allergic Reaction Induced by Diclofenac Sodium Lidocaine Injection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(11): 703-704.
| [1] 黄秋明. 双氯芬酸所致不良反应63例分析[J].中国药师,2009,12(1):99-101. [2] 张美霞,朱迎英.含双氯芬酸抗炎药的不良反应回顾[J].海峡药学, 2013, 25(5):294-296. [3] 吴文利,王晓旭,王基云,等.双氯芬酸钠盐酸利多卡因注射液致喉头水肿1例[J].中国药物警戒, 2017, 14(10):639-640. [4] 彭卫珍,陈华,孔令春.双氯芬酸钠致不良反应46例分析[J].医药导报, 2012, 31(3):392-394. [5] 崔艺,袁俊波. 双氯芬酸钠所致过敏反应文献概述[J].中国药物滥用防治杂志, 2016, 22(1):47-48. [6] 闫敏,吴苗苗.双氯芬酸钠栓剂致过敏性休克[J].中国误诊学杂志, 2011,11(28):6901. [7] 胡利群,方琴,苏洲.肌注双氯芬酸钠盐酸利多卡因注射液致过敏性休克1例[J].中国医药用药评价与分析, 2015,15(12):1709-1710. [8] 耿艳莉,龚云.双氯芬酸钠栓致过敏性休克1例[J].医药导报, 2008, 27(11):1333. [9] 夏敬民,彭强,陈家璇.复方双氯芬酸钠注射液过敏1例[J].药物流行病学杂志, 2002, 11(2):99. [10] 付玉芳,乙苏北,吴世凯,等.双氯芬酸钠肠溶片致严重变态反应1例[J].医药导报, 2001, 30(7):925. [11] 金怡,盛敏,褚雪文.双氯芬酸钠缓释片致严重过敏反应1例[J].中国药师, 2014, 39(10):1748. [12] 陈霞. 双氯芬酸钠栓致过敏反应[J].药物不良反应杂志,2011,13(6):393. |
| [1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
| [2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
| [3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
| [4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
| [5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
| [6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
| [7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
| [8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
| [9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
| [10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
| [11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
| [12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
| [13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
| [14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
| [15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
